Home
About Us
Who We Are
Our Niche
Our Results
Recent Placements
Replacement Policy
Our Brochures
Our Team
Hot Jobs
Search Services
Search Services
Diversity & Inclusion
Code of Ethics
Awards & Recognitions
Career Coaching
Resources
Recruiter Tips
News and Insights
Resume Resources
Working From Home
My Inspirement
Healthy Living for Executives
Testimonials
AI Training and Quality Disclosure
Contact Us

The Bandish Group

Home
About Us
Who We Are
Our Niche
Our Results
Recent Placements
Replacement Policy
Our Brochures
Our Team
Hot Jobs
Search Services
Search Services
Diversity & Inclusion
Code of Ethics
Awards & Recognitions
Career Coaching
Resources
Recruiter Tips
News and Insights
Resume Resources
Working From Home
My Inspirement
Healthy Living for Executives
Testimonials
AI Training and Quality Disclosure
Contact Us
Jackie Bandish
July 5, 2022

AstraZeneca to buy TeneoTwo

Jackie Bandish
July 5, 2022

AstraZeneca has announced a $1.28B plan to purchase TeneoTwo, a U.S. oncology firm. AstraZeneca said the purchase will be focused on a molecule made by the company that is designed to encourage the body's immune system to target and kill cancer cells.

Click here to read the entire article.

Newer PostLiquid epilepsy drug approved by the FDA
Older PostDoug Ward named CEO of Lumos Diagnostics
Back to Top
Home
About Us
Who We Are
Our Niche
Our Results
Recent Placements
Replacement Policy
Our Brochures
Our Team
Hot Jobs
Search Services
Search Services
Diversity & Inclusion
Code of Ethics
Awards & Recognitions
Career Coaching
Resources
Recruiter Tips
News and Insights
Resume Resources
Working From Home
My Inspirement
Healthy Living for Executives
Testimonials
AI Training and Quality Disclosure
Contact Us
The Bandish Group, LLC, Bucks County, PA267-483-5233info@bandishgroup.com

Headquarters: Greater Philadelphia Area